TABLE 1.
Baseline characteristics of study participants by diet1
| ACS (n = 20) | KD (n = 25) | |
|---|---|---|
| Age, y | 58.6 ± 11.7 | 61.5 ± 8.5 |
| Race, white/black/Asian, n/n/n | 17/3/0 | 22/2/1 |
| BMI, kg/m2 | 33.0 ± 10.7 | 30.7 ± 8.0 |
| Ovarian cancer, stage I/II/III/IV, n/n/n/n | 3/3/6/1 | 2/2/10/1 |
| Endometrial cancer, stage I/II/III/IV, n/n/n/n | 6/0/1/0 | 7/2/1/0 |
| Receiving concurrent chemotherapy, % | 4 (20.0) | 7 (28.0) |
| Previous chemotherapies, n | 2.4 ± 1.6 | 1.6 ± 1.4 |
| Time since initial diagnosis, y | 4.9 ± 5.0 | 2.4 ± 3.0 |
1
Values are means ± SDs unless otherwise indicated. ACS, American Cancer Society diet; KD, ketogenic diet.